Central European Journal of Medicine

, Volume 8, Issue 1, pp 117–124 | Cite as

Common variants of the mineralocorticoid and glucocorticoid receptor genes may contribute to pregnancy-related anxiety: a pilot study

  • Natalia V. Chistiakova
  • Elena A. Sergienko
  • Kirill V. Savost’ianov
Research Article


The hypothalamic-pituitary-adrenal (HPA) axis overactivity is thought to contribute to increased vulnerability to maternal stress. We hypothesize that functionally relevant polymorphic variants of the glucocorticoid (NR3C1) and mineralocorticoid (NR3C2) receptor genes mediating biological effects of cortisol, a major stress hormone, could also modulate the capacity to cope with pregnancy-related anxiety. Genomic DNA from the blood of 42 women with pregnancy-related anxiety and 42 age-matched women with normal pregnancy (5–6th months of gestation) were genotyped for markers rs6195 and rs10482605 of NR3C1 and two NR3C2 polymorphisms (rs5522 and rs2070951) using a Taqman allele discrimination assay. Serum total cortisol was measured using an ELISA technique. The allele Ser363 of rs6195 (the N363S polymorphism of NR3C1) was found to be associated with a higher risk of maternal stress (odds ratio (OR)=5.27; P=0.001). For NR3C2, the allele Val180 of rs5522 (I180V) also showed association with increased risk of neonatal stress (OR=1.97; P=0.038). Both predisposing gene variants were also associated with significantly elevated levels of cortisol in normally pregnant women and females with pregnancy-related anxiety. Our results suggest that pregnancy-related anxiety can be modulated by variants of NR3C1 and NR3C2 associated with increased basal cortisol levels. Thus, our findings provide evidence in support of the suggestion that elevated cortisol levels and HPA axis hyperactivity are implicated in pregnancy-related anxiety.


Pregnancy-related anxiety HPA axis Cortisol Mineralocorticoid receptor Glucocorticoid receptor Polymorphism 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. [1]
    Austin MP, Leader L. Maternal stress and obstetric and infant outcomes: epidemiological findings and neuroendocrine mechanisms. Aust N Z J Obstet Gynaecol 2000, 40, 331–337PubMedCrossRefGoogle Scholar
  2. [2]
    Low LA, Schweinhardt P. Early life adversity as a risk factor for fibromyalgia in later life. Pain Res Treat 2012, 2012:140832PubMedGoogle Scholar
  3. [3]
    Gungor I, Oskay U, Beji NK. Biopsychosocial risk factors for preterm birth and postpartum emotional well-being: a case-control study on Turkish women without chronic illnesses. J Clin Nurs 2011, 20, 653–665PubMedCrossRefGoogle Scholar
  4. [4]
    Vettore MV, Gama SG, Lamarca Gde A, Schilithz AO, Leal Mdo C. Housing conditions as a social determinant of low birthweight and preterm low birthweight. Rev Saude Publica 2010, 44, 1021–1031PubMedCrossRefGoogle Scholar
  5. [5]
    Precht DH, Andersen PK, Olsen J. Severe life events and impaired fetal growth: a nation-wide study with complete follow-up. Acta Obstet Gynecol Scand 2007, 86, 266–275PubMedCrossRefGoogle Scholar
  6. [6]
    Precht DH, Andersen PK, Olsen J. Severe life events and impaired fetal growth: a nation-wide study with complete follow-up. Acta Obstet Gynecol Scand 2007, 86, 266–275PubMedCrossRefGoogle Scholar
  7. [7]
    Henriksen TB, Hedegaard M, Secher NJ, Wilcox AJ. Standing at work and preterm delivery. Br J Obstet Gynaecol 1995, 102, 198–206PubMedCrossRefGoogle Scholar
  8. [8]
    Hedegaard M, Henriksen TB, Sabroe S, Secher NJ. The relationship between psychological distress during pregnancy and birth weight for gestational age. Acta Obstet Gynecol Scand 1996, 75, 32–39PubMedCrossRefGoogle Scholar
  9. [9]
    Maina G, Saracco P, Giolito MR, Danelon D, Bogetto F, Todros T. Impact of maternal psychological distress on fetal weight, prematurity and intrauterine growth retardation. J Affect Disord 2008, 111, 214–220PubMedCrossRefGoogle Scholar
  10. [10]
    McLean M, Bisits A, Davies J, Woods R, Lowry P, Smith R. A placental clock controlling the length of human pregnancy. Nat Med 1995, 1, 460–463PubMedCrossRefGoogle Scholar
  11. [11]
    Majzoub JA, McGregor JA, Lockwood CJ, Lockwood CJ, Smith R, Taggart MS, et al. A central theory of preterm and term labor: putative role for corticotropin-releasing hormone. Am J Obstet Gynecol 1999, 180, S232–S241PubMedCrossRefGoogle Scholar
  12. [12]
    Wadhwa PD, Porto M, Garite TJ, Chicz-DeMet A, Sandman CA. Maternal corticotropin-releasing hormone levels in the early third trimester predict length of gestation in human pregnancy. Am J Obstet Gynecol 1998, 179, 1079–1085PubMedCrossRefGoogle Scholar
  13. [13]
    Hobel CJ, Dunkel-Schetter C, Roesch SC, Castro LC, Arora CP. Maternal plasma corticotropinreleasing hormone associated with stress at 20 weeks’ gestation in pregnancies ending in preterm delivery. Am J Obstet Gynecol 1999,180, S257–S263PubMedCrossRefGoogle Scholar
  14. [14]
    McLean M. Bisits A. Davies J, Walters W, Hackshaw A, De Voss K, Smith R. Predicting risk of preterm delivery by second-trimester measurement of maternal plasma corticotropin-releasing hormone and a-fetoprotein concentrations. Am J Obstet Gynecol 1999, 181, 207–215PubMedCrossRefGoogle Scholar
  15. [15]
    Class QA, Lichtenstein P, Långström N, D’Onofrio BM. Timing of prenatal maternal exposure to severe life events and adverse pregnancy outcomes: a population study of 2.6 million pregnancies. Psychosom Med 2011, 73, 234–241PubMedCrossRefGoogle Scholar
  16. [16]
    Mancuso RA, Schetter CD, Rini CM, Roesch SC, Hobel CJ. Maternal prenatal anxiety and corticotropin-releasing hormone associated with timing of delivery. Psychosom Med 2004, 66, 762–769PubMedCrossRefGoogle Scholar
  17. [17]
    Clark C, Ryan L, Kawachi I, Canner MJ, Berkman L, Wright RJ. Witnessing community violence in residential neighborhoods: A mental health hazard for urban women. J Urban Health 2008, 85, 22–38PubMedCrossRefGoogle Scholar
  18. [18]
    Lindsay JR, Nieman LK. The hypothalamic-pituitaryadrenal axis in pregnancy: challenges in disease detection and treatment. Endocr Rev 2005, 26, 775–799PubMedCrossRefGoogle Scholar
  19. [19]
    Derijk RH. Single nucleotide polymorphisms related to HPA axis reactivity. Neuroimmunomodulation 2009, 16, 340–352PubMedCrossRefGoogle Scholar
  20. [20]
    Mormede P, Foury A, Barat P, Corcuff JB, Terenina E, Marissal-Arvy N, et al. Molecular genetics of hypothalamic-pituitary-adrenal axis activity and function. Ann N Y Acad Sci 2011, 1220, 127–136PubMedCrossRefGoogle Scholar
  21. [21]
    Lanfumey L, Mongeau R, Cohen-Salmon C, Hamon M. Corticosteroid-serotonin interactions in the neurobiological mechanisms of stress-related disorders. Neurosci Biobehav Rev 2008, 32, 1174–1184PubMedCrossRefGoogle Scholar
  22. [22]
    Craig IW. The importance of stress and genetic variation in human aggression. Bioessays 2007, 29, 227–236PubMedCrossRefGoogle Scholar
  23. [23]
    Porter RJ, Gallagher P, Watson S, Young AH. Corticosteroid-serotonin interactions in depression: a review of the human evidence. Psychopharmacology (Berl) 2004, 173, 1–17CrossRefGoogle Scholar
  24. [24]
    Neumann ID, Veenema AH, Beiderbeck DI. Aggression and anxiety: social context and neurobiological links. Front Behav Neurosci 2010, 4:12PubMedGoogle Scholar
  25. [25]
    Lippman ME, Halterman RH, Leventhal BG, Perry S, Thompson EB. Glucocorticoid-binding proteins in human acute lymphoblastic leukemic blast cells. J Clin Invest 1973, 52, 1715–1725PubMedCrossRefGoogle Scholar
  26. [26]
    Roesch SC, Dunkel-Schetter C, Woo G, Hobel CJ. Modeling the types and timing of stress in pregnancy. J Anx Str Cop 2004, 17, 87–102CrossRefGoogle Scholar
  27. [27]
    Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav 1983, 24, 386–396CrossRefGoogle Scholar
  28. [28]
    Spielberger CD. Manual for the State-Trait Anxiety Inventory. Consulting Psychologists Press, Palo Alto, CA, 1983Google Scholar
  29. [29]
    Lobel M, Dunkel-Schetter C, Scrimshaw SCM. Prenatal maternal stress and prematurity: a prospective study of socioeconomically disadvantaged women. Health Psychol 1992, 11, 32–40PubMedCrossRefGoogle Scholar
  30. [30]
    Klok MD, Vreeburg SA, Penninx BW, Zitman FG, de Kloet ER, DeRijk RH. Common functional mineralocorticoid receptor polymorphisms modulate the cortisol awakening response: Interaction with SSRIs. Psychoneuroendocrinology 2011, 36, 484–494PubMedCrossRefGoogle Scholar
  31. [31]
    Geelhoed MJ, Steegers EA, Koper JW, van Rossum EF, Moll HA, Raat H, et al. Glucocorticoid receptor gene polymorphisms do not affect growth in fetal and early postnatal life. The Generation R Study. BMC Med Genet, 2010, 11:39PubMedCrossRefGoogle Scholar
  32. [32]
    Bland JM, Altman DG. Statistics notes. The odds ratio. BMJ 2000, 320, 1468PubMedCrossRefGoogle Scholar
  33. [33]
    Zhao JH. 2LD, GENECOUNTING and HAP: computer programs for linkage disequilibrium analysis. Bioinformatics 2004, 20, 1325–1326PubMedCrossRefGoogle Scholar
  34. [34]
    Derijk RH, de Kloet ER. Corticosteroid receptor polymorphisms: determinants of vulnerability and resilience. Eur J Pharmacol 2008, 583, 303–311PubMedCrossRefGoogle Scholar
  35. [35]
    van Leeuwen N, Kumsta R, Entringer S, de Kloet ER, Zitman FG, DeRijk RH, et al. Functional mineralocorticoid receptor (MR) gene variation influences the cortisol awakening response after dexamethasone. Psychoneuroendocrinology 2010, 35, 339–349PubMedCrossRefGoogle Scholar
  36. [36]
    Muhtz C, Zyriax BC, Bondy B, Windler E, Otte C. Association of a common mineralocorticoid receptor gene polymorphism with salivary cortisol in healthy adults. Psychoneuroendocrinology 2011, 36, 298–301PubMedCrossRefGoogle Scholar
  37. [37]
    van Leeuwen N, Bellingrath S, de Kloet ER, Zitman FG, DeRijk RH, Kudielka BM, Wüst S. Human mineralocorticoid receptor (MR) gene haplotypes modulate MR expression and transactivation: implication for the stress response. Psychoneuroendocrinology 2011, 36, 699–709PubMedCrossRefGoogle Scholar
  38. [38]
    DeRijk RH, Wüst S, Meijer OC, Zennaro MC, Federenko IS, Hellhammer DH, et al. A common polymorphism in the mineralocorticoid receptor modulates stress responsiveness. J Clin Endocrinol Metab 2006, 91, 5083–5089PubMedCrossRefGoogle Scholar
  39. [39]
    Bogdan R, Perlis RH, Fagerness J, Pizzagalli DA. The impact of mineralocorticoid receptor ISO/VAL genotype (rs5522) and stress on reward learning. Genes Brain Behav 2010, 9, 658–667PubMedGoogle Scholar
  40. [40]
    Kumsta R, Moser D, Streit F, Koper JW, Meyer J, Wüst S. Characterization of a glucocorticoid receptor gene (GR, NR3C1) promoter polymorphism reveals functionality and extends a haplotype with putative clinical relevance. Am J Med Genet B Neuropsychiatr Genet 2009, 150B, 476–482PubMedCrossRefGoogle Scholar
  41. [41]
    Gaitan D, DeBold CR, Turney MK, Zhou P, Orth DN, Kovacs WJ. Glucocorticoid receptor structure and function in an adrenocorticotropin-secreting small cell lung cancer. Mol Endocrinol 1995, 9, 1193–1201PubMedCrossRefGoogle Scholar
  42. [42]
    Huizenga NA, Koper JW, De Lange P, Pols HA, Stolk RP, Burger H, et al. A polymorphism in the glucocorticoid receptor gene may be associated with and increased sensitivity to glucocorticoids in vivo. J Clin Endocrinol Metab 1998, 83, 144–151PubMedCrossRefGoogle Scholar
  43. [43]
    Russcher H, Smit P, van den Akker EL, van Rossum EF, Brinkmann AO, de Jong FH, et al. Two polymorphisms in the glucocorticoid receptor gene directly affect glucocorticoid-regulated gene expression. J Clin Endocrinol Metab 2005, 90, 5804–5810PubMedCrossRefGoogle Scholar
  44. [44]
    Wüst S, Van Rossum EF, Federenko IS, Koper JW, Kumsta R, Hellhammer DH. Common polymorphisms in the glucocorticoid receptor gene are associated with adrenocortical responses to psychosocial stress. J Clin Endocrinol Metab 2004, 89, 565–573PubMedCrossRefGoogle Scholar
  45. [45]
    DeRijk R, de Kloet ER. Corticosteroid receptor genetic polymorphisms and stress responsivity. Endocrine 2005, 28, 263–270PubMedCrossRefGoogle Scholar
  46. [46]
    Kumsta R, Entringer S, Koper JW, van Rossum EF, Hellhammer DH, Wüst S. Sex- specific associations between common glucocorticoid receptor gene variants and hypothalamus-pituitary-adrenal axis responses to psychosocial stress. Biol Psychiatry 2007, 62, 863–899PubMedCrossRefGoogle Scholar
  47. [47]
    Crider KS, Whitehead N, Buus RM. Genetic variation associated with preterm birth: a HuGE review. Genet Med 2005, 7, 593–604PubMedCrossRefGoogle Scholar
  48. [48]
    Spivak IM, Smirnova TIu, Gruzdev NV, Shneĭder OV, Abramchenko VV, Spivak DL. Possible correlation of polymorphism of angiotensin-converting enzyme gene with psychological aspects of birth stress. Tsitologiia 2006, 48, 875–882 (in Russian)PubMedGoogle Scholar
  49. [49]
    Spivak IM, Seĭlieva NA, Smirnova TIu, Bolotskikh VM, Abramchenko VV, Spivak DL. Polymorphisms of genes of rennin-angiotensin system and their correlation with psychological manifestations of birth stress. Tsitologiia 2008, 50, 899–906 (in Russian)PubMedGoogle Scholar
  50. [50]
    El Hage W, Powell JF, Surguladze SA. Vulnerability to depression: what is the role of stress genes in gene x environment interaction? Psychol Med 2009, 39, 1407–1411PubMedCrossRefGoogle Scholar

Copyright information

© Versita Warsaw and Springer-Verlag Berlin Heidelberg 2012

Authors and Affiliations

  • Natalia V. Chistiakova
    • 1
  • Elena A. Sergienko
    • 1
  • Kirill V. Savost’ianov
    • 2
  1. 1.Department of Developmental Psychology, Institute of PsychologyRussian Academy of ScienceMoscowRussia
  2. 2.Department of Molecular DiagnosticsNational Research Center GosNIIgenetikaMoscowRussia

Personalised recommendations